Clinical Trial Update: Efficacy and Safety of Glycopyrrolate Bromide of COPD Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update on glycopyrrolate bromide in COPD evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• glycopyrrolate bromide (glycopyrrolate bromide)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED